VANCOUVER, British Columbia, May 23, 2012 (GLOBE NEWSWIRE) -- The Board of Directors of QLT Inc. (Nasdaq:QLTI) (TSX:QLT) (“QLT” or the “Company”) today issued an open letter to stockholders in response to a filing made by NB Public Equity Komplementar ApS (“Nordic Biotech”) proposing a dissident slate of directors for election at the Company’s annual general meeting of shareholders on May 24, 2012.
